About
Basic Data Updated:
24 days agoThe manufacturing of pharmaceutical products is the main focus of Delexcel Pharma Private Limited. A recent credit rating report revealed that the company's manufacturing plant is located in Telangana. The company was established with the purpose of engaging in the production, formulation, processing, development, refinement, import, export, wholesale, and/or retail trade of various pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths, and other restoratives or foods. Additionally, the company also deals in medicinal goods such as surgical instruments, contraceptives, photographic goods, oils, and perfumes.
Industry
Company Details
- Location
Medak, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24232TG2014PTC095535 |
| Company No. | 095535 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 04 Sep 2014 |
| Date of AGM | 30 Sep 2022 |
| Date of Balance Sheet | 31 Mar 2022 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Delexcel Pharma Private Limited
Delexcel Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 38.33% increase. The company also saw a substantial improvement in profitability, with a 84.47% increase in profit. The company's net worth observed a substantial decline by a decrease of 47.84%.
Corporate Structure
Unlock access to Delexcel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Delexcel Pharma Private Limited
Unlock and access historical data on people associated with Delexcel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
Raghupathi Kandarapu
CEOAppointment Date: 06-Jun-2016
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Feb 2017 | ₹25.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delexcel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delexcel Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Tmr Developers Private Limited
Active
11 years 8 months Madhava Tumati and Venkata Tumati are mutual person
Recent activity within the organization
Annual General Meeting
Delexcel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
30 Sep 2022Balance Sheet
Delexcel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
31 Mar 2022Charges
A charge with Others of Rs. 25.00 cr registered on 22 Feb 2017 with Charge ID 100079773 was modified on 02 Jan 2018.
02 Jan 2018Charges
A charge with Others amounted to Rs. 25.00 cr with Charge ID 100079773 was registered on 22 Feb 2017.
22 Feb 2017Director Appointment
Raghupathi Kandarapu was appointed as a Ceo was appointed as a Ceo on 06 Jun 2016 & has been associated with this company since 7 years 11 months .
06 Jun 2016
Frequently asked questions
What is the Incorporation or founding date of Delexcel Pharma Private Limited?
